Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 3

Sponsor Class

OTHER 3NIH 1NETWORK 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Genitourinary 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Prostatic Neoplasms 1Neoplasms 1Colorectal Neoplasms 1Cardiotoxicity 1

Interventions

Cyclophosphamide 548pembrolizumab 385Radiotherapy 363Bevacizumab 360Carboplatin 351Rituximab 315Cisplatin 300Gemcitabine 297Paclitaxel 288Dexamethasone 272Docetaxel 271fludarabine phosphate 241Doxorubicin 231Nivolumab 220Etoposide 209Cytarabine 203Lenalidomide 201fludarabine 191Oxaliplatin 191Fluorouracil 190Melphalan 189Filgrastim 188Capecitabine 175Calcium Dobesilate 172Radiosurgery 167Erlotinib Hydrochloride 167Methotrexate 163Bortezomib 162Granulocyte Colony-Stimulating Factor 154Whole-Body Irradiation 144

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Has results × Exercise Test × Clear all
NCT06016725 2026-01-02

E-PROOF

Ohio State University Comprehensive Cancer Center

Phase NA Completed
75 enrolled 27 charts
GastrointestinalGenitourinary

Prostatic Neoplasms, Colorectal Neoplasms

NCT01186367 2025-02-10

Excite

Memorial Sloan Kettering Cancer Center

Phase NA Completed
174 enrolled 11 charts
Breast

Breast Neoplasms

NCT01719562 2023-05-19

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Wake Forest University Health Sciences

Phase NA Completed
28 enrolled 17 charts
Breast

Breast Neoplasms, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡